Sinopharm Group Co. Ltd. (SHTDY)
OTC: SHTDY
· Real-Time Price · USD
11.97
0.00 (0.03%)
At close: Oct 03, 2025, 3:58 PM
11.97
-0.03%
After-hours: Oct 01, 2025, 08:00 PM EDT
Sinopharm Balance Sheet Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 47.16B | 54.31B | 43.33B | 63.81B | 34.38B | 55.22B | 32.15B | 43.53B | 34.36B |
Short-Term Investments | n/a | 158K | 553K | 547K | 422K | 498K | 347K | 11.75M | 169K |
Long-Term Investments | 10.55B | 10.89B | 10.6B | 10.55B | 10.09B | 9.84B | 9.64B | 9.17B | 8.74B |
Other Long-Term Assets | 9.62B | 1.48B | 6.4B | 6.1B | 3.55B | 3.73B | 3.58B | 3.73B | 4B |
Receivables | 244.13B | 206.72B | 242.41B | 185.79B | 241.48B | 171.2B | 211.75B | 172.58B | 191.11B |
Inventory | 65.52B | 62.35B | 68.84B | 60.03B | 66.92B | 60.93B | 56.99B | 51.5B | 50.82B |
Other Current Assets | 17.09B | 14.05B | 27.78B | 16.18B | 270.85B | 187.77B | 220.59B | 185.97B | 199.28B |
Total Current Assets | 373.9B | 347.45B | 382.36B | 336.84B | 372.15B | 319.41B | 325.26B | 290.92B | 299.95B |
Property-Plant & Equipment | 15.9B | 19.63B | 20.1B | 19.9B | 19.66B | 17.79B | 19.38B | 17.6B | 18.94B |
Goodwill & Intangibles | 10.2B | 10.97B | 10.12B | 10.02B | 10.14B | 12.03B | 10.29B | 12.2B | 11.01B |
Total Long-Term Assets | 46.27B | 45.38B | 47.22B | 46.56B | 45.54B | 45.37B | 44.92B | 44.49B | 44.38B |
Total Assets | 420.17B | 392.83B | 429.58B | 383.39B | 417.69B | 364.78B | 370.18B | 335.41B | 344.33B |
Account Payables | 152.67B | 156.87B | 155.83B | 154.75B | 156.64B | 144.62B | 131.28B | 132.87B | 121.33B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 85.91B | 62.73B | 79.69B | 54.73B | 74.67B | 53B | 76.66B | 55.15B | 71.83B |
Other Current Liabilities | 39.54B | 16.57B | 11.15B | 17.52B | 44.05B | 21.95B | 35.58B | 17.73B | 34.3B |
Total Current Liabilities | 279.78B | 250.38B | 283.24B | 241.49B | 281.31B | 234.96B | 248.98B | 219.31B | 232.32B |
Long-Term Debt | 4.44B | 8.64B | 15.93B | 13.83B | 15.23B | 11.75B | 10.38B | 8.42B | 10.32B |
Other Long-Term Liabilities | 3.53B | 3.87B | 4.31B | 3.09B | 4.74B | 4.79B | 4.71B | 4.78B | 5.23B |
Total Long-Term Liabilities | 10.91B | 15.77B | 23.91B | 21.59B | 23.27B | 19.74B | 18.45B | 16.45B | 18.84B |
Total Liabilities | 290.7B | 266.14B | 307.15B | 263.08B | 304.58B | 254.71B | 267.43B | 235.76B | 251.15B |
Total Debt | 93.29B | 76.39B | 101.06B | 73.78B | 94.83B | 69.59B | 91.9B | 68.37B | 86.79B |
Book Value | 129.47B | 126.69B | 122.43B | 120.32B | 113.11B | 110.07B | 102.75B | 99.65B | 93.18B |
Book Value Per Share | 207.82 | 203.47 | 196.17 | 193.02 | 181.45 | 176.46 | 164.83 | 159.67 | 149.29 |
Common Stock | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B | 3.12B |
Retained Earnings | 56.79B | 53.74B | 50.4B | 49.41B | n/a | 42.87B | n/a | 38.52B | n/a |
Comprehensive Income | 20.19M | 22.02B | 22.03B | n/a | 66.49B | -4.39B | 60.12B | -4.39B | 54.67B |
Shareholders Equity | 80.38B | 78.88B | 75.54B | 74.58B | 69.6B | 68.07B | 63.24B | 61.89B | 57.79B |
Total Investments | 10.55B | 10.89B | 10.6B | 10.55B | 10.09B | 9.84B | 9.64B | 9.18B | 8.74B |